Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin-gemcitabine or carboplatin-paclitaxel: NVALT-3 a phase III study. [electronic resource]
Producer: 20111027Description: 1520-1527 p. digitalISSN:- 1569-8041
- Adenocarcinoma -- drug therapy
- Adenocarcinoma, Bronchiolo-Alveolar -- drug therapy
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carboplatin -- administration & dosage
- Carcinoma, Large Cell -- drug therapy
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Carcinoma, Squamous Cell -- drug therapy
- Deoxycytidine -- administration & dosage
- Female
- Follow-Up Studies
- Geriatric Assessment
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Paclitaxel -- administration & dosage
- Quality of Life
- Survival Rate
- Treatment Outcome
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.